Literature DB >> 23937674

Lessons learned from gene expression profiling of cutaneous T-cell lymphoma.

B O Dulmage1, L J Geskin.   

Abstract

Gene expression studies of cutaneous T-cell lymphoma (CTCL) span a decade, yet the pathogenesis is poorly understood and diagnosis remains a challenge. This review examines the varied approaches to gene expression analysis of CTCL, with emphasis on cell populations, control selection and expression data collection. Despite discordant results, several dysregulated genes have been identified across multiple studies, including PLS3, KIR3DL2, TWIST1 and STAT4. Here, we provide an overview of the most consistently expressed genes across different studies and bring them together through common pathways biologically relevant to CTCL. Four pathways - evasion of activation-induced cell death, T helper 2 lymphocyte differentiation, transforming growth factor-β receptor expression, and tumour necrosis factor receptor ligands - appear to encompass the most frequently affected genes, hypothetically providing insight into the disease pathogenesis.
© 2013 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23937674      PMCID: PMC3954533          DOI: 10.1111/bjd.12578

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  86 in total

1.  Activation of EphA receptors on CD4+CD45RO+ memory cells stimulates migration.

Authors:  H L Holen; K Nustad; H-C Aasheim
Journal:  J Leukoc Biol       Date:  2010-02-16       Impact factor: 4.962

2.  Low FAS/CD95 expression by CTCL correlates with reduced sensitivity to apoptosis that can be restored by FAS upregulation.

Authors:  Jianqiang Wu; Minakshi Nihal; Jawed Siddiqui; Eric C Vonderheid; Gary S Wood
Journal:  J Invest Dermatol       Date:  2008-10-16       Impact factor: 8.551

3.  MicroRNA expression in Sezary syndrome: identification, function, and diagnostic potential.

Authors:  Erica Ballabio; Tracey Mitchell; Marloes S van Kester; Stephen Taylor; Heather M Dunlop; Jianxiang Chi; Isabella Tosi; Maarten H Vermeer; Daniela Tramonti; Nigel J Saunders; Jacqueline Boultwood; James S Wainscoat; Francesco Pezzella; Sean J Whittaker; Cornelius P Tensen; Christian S R Hatton; Charles H Lawrie
Journal:  Blood       Date:  2010-05-06       Impact factor: 22.113

4.  Novel approach to gene expression profiling in Sézary syndrome.

Authors:  R G Pomerantz; E D Mirvish; G Erdos; L D Falo; L J Geskin
Journal:  Br J Dermatol       Date:  2010-11       Impact factor: 9.302

5.  Variable CD52 expression in mature T cell and NK cell malignancies: implications for alemtuzumab therapy.

Authors:  Liuyan Jiang; Constance M Yuan; Julia Hubacheck; John E Janik; Wyndham Wilson; John C Morris; Gregory A Jasper; Maryalice Stetler-Stevenson
Journal:  Br J Haematol       Date:  2009-02-19       Impact factor: 6.998

6.  Induction of T-cell responses against cutaneous T-cell lymphomas ex vivo by autologous dendritic cells transfected with amplified tumor mRNA.

Authors:  Xiao Ni; Heather M Richmond; Xingsheng M Liao; William K Decker; Lisa H Shiue; Elizabeth J Shpall; Madeleine Duvic
Journal:  J Invest Dermatol       Date:  2008-05-15       Impact factor: 8.551

7.  A genomic and expression study of AP-1 in primary cutaneous T-cell lymphoma: evidence for dysregulated expression of JUNB and JUND in MF and SS.

Authors:  Xin Mao; Guy Orchard; Tracey J Mitchell; Noritaka Oyama; Robin Russell-Jones; Maarten H Vermeer; Rein Willemze; Remko van Doorn; Cornelis P Tensen; Bryan D Young; Sean J Whittaker
Journal:  J Cutan Pathol       Date:  2008-06-28       Impact factor: 1.587

8.  Lack of T-cell receptor-induced signaling is crucial for CD95 ligand up-regulation and protects cutaneous T-cell lymphoma cells from activation-induced cell death.

Authors:  Claus-Detlev Klemke; Dirk Brenner; Eva-Maria Weiss; Marc Schmidt; Martin Leverkus; Karsten Gülow; Peter H Krammer
Journal:  Cancer Res       Date:  2009-05-12       Impact factor: 12.701

9.  Oncogenomic analysis of mycosis fungoides reveals major differences with Sezary syndrome.

Authors:  Remco van Doorn; Marloes S van Kester; Remco Dijkman; Maarten H Vermeer; Aat A Mulder; Karoly Szuhai; Jeroen Knijnenburg; Judith M Boer; Rein Willemze; Cornelis P Tensen
Journal:  Blood       Date:  2008-10-01       Impact factor: 22.113

10.  Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis.

Authors:  Sunhwa Kim; Hiroyuki Takahashi; Wan-Wan Lin; Pascal Descargues; Sergei Grivennikov; Youngjun Kim; Jun-Li Luo; Michael Karin
Journal:  Nature       Date:  2009-01-01       Impact factor: 49.962

View more
  20 in total

1.  Gene expression analysis in Cutaneous T-Cell Lymphomas (CTCL) highlights disease heterogeneity and potential diagnostic and prognostic indicators.

Authors:  Ivan V Litvinov; Michael T Tetzlaff; Philippe Thibault; Pamela Gangar; Linda Moreau; Andrew K Watters; Elena Netchiporouk; Kevin Pehr; Victor G Prieto; Elham Rahme; Nathalie Provost; Martin Gilbert; Denis Sasseville; Madeleine Duvic
Journal:  Oncoimmunology       Date:  2017-03-17       Impact factor: 8.110

2.  The Use of Transcriptional Profiling to Improve Personalized Diagnosis and Management of Cutaneous T-cell Lymphoma (CTCL).

Authors:  Ivan V Litvinov; Elena Netchiporouk; Brendan Cordeiro; Marc-André Doré; Linda Moreau; Kevin Pehr; Martin Gilbert; Youwen Zhou; Denis Sasseville; Thomas S Kupper
Journal:  Clin Cancer Res       Date:  2015-03-16       Impact factor: 12.531

3.  Chromatin Accessibility Landscape of Cutaneous T Cell Lymphoma and Dynamic Response to HDAC Inhibitors.

Authors:  Kun Qu; Lisa C Zaba; Ansuman T Satpathy; Paul G Giresi; Rui Li; Yonghao Jin; Randall Armstrong; Chen Jin; Nathalie Schmitt; Ziba Rahbar; Hideki Ueno; William J Greenleaf; Youn H Kim; Howard Y Chang
Journal:  Cancer Cell       Date:  2017-06-15       Impact factor: 31.743

4.  Interleukin-13 is overexpressed in cutaneous T-cell lymphoma cells and regulates their proliferation.

Authors:  Larisa J Geskin; Sara Viragova; Donna B Stolz; Patrizia Fuschiotti
Journal:  Blood       Date:  2015-01-27       Impact factor: 22.113

Review 5.  The biomarker landscape in mycosis fungoides and Sézary syndrome.

Authors:  Brittany Dulmage; Larisa Geskin; Joan Guitart; Oleg E Akilov
Journal:  Exp Dermatol       Date:  2017-02-02       Impact factor: 3.960

6.  Bortezomib inhibits expression of TGF-β1, IL-10, and CXCR4, resulting in decreased survival and migration of cutaneous T cell lymphoma cells.

Authors:  Tzu-Pei Chang; Vladimir Poltoratsky; Ivana Vancurova
Journal:  J Immunol       Date:  2015-02-13       Impact factor: 5.422

7.  Ectopic expression of embryonic stem cell and other developmental genes in cutaneous T-cell lymphoma.

Authors:  Ivan V Litvinov; Elena Netchiporouk; Brendan Cordeiro; Hanieh Zargham; Kevin Pehr; Martin Gilbert; Youwen Zhou; Linda Moreau; Anders Woetmann; Niels Ødum; Thomas S Kupper; Denis Sasseville
Journal:  Oncoimmunology       Date:  2014-12-21       Impact factor: 8.110

Review 8.  Twist as a new prognostic marker in hematological malignancies.

Authors:  F Norozi; A Ahmadzadeh; M Shahjahani; S Shahrabi; N Saki
Journal:  Clin Transl Oncol       Date:  2015-07-24       Impact factor: 3.405

9.  BIN1 tumor suppressor regulates Fas/Fas ligand-mediated apoptosis through c-FLIP in cutaneous T-cell lymphoma.

Authors:  S Esmailzadeh; Y Huang; M-W Su; Y Zhou; X Jiang
Journal:  Leukemia       Date:  2015-01-12       Impact factor: 11.528

10.  Versican upregulation in Sézary cells alters growth, motility and resistance to chemotherapy.

Authors:  K Fujii; M B Karpova; K Asagoe; O Georgiev; R Dummer; M Urosevic-Maiwald
Journal:  Leukemia       Date:  2015-04-27       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.